(S)-METHYL-2-[2-(5-FLUORO-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-ACETAMIDO]-3-METHYLBUTANOATE
Compound with spectra: 1 NMR
![(S)-METHYL-2-[2-(5-FLUORO-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-ACETAMIDO]-3-METHYLBUTANOATE](/api/compound/GvbLDTu7cdI.png?ph=true&h=300&w=458 "(S)-METHYL-2-[2-(5-FLUORO-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-ACETAMIDO]-3-METHYLBUTANOATE")
| SpectraBase Compound ID | GvbLDTu7cdI |
|---|---|
| InChI | InChI=1S/C12H16FN3O5/c1-6(2)9(11(19)21-3)14-8(17)5-16-4-7(13)10(18)15-12(16)20/h4,6,9H,5H2,1-3H3,(H,14,17)(H,15,18,20)/t9-/m0/s1 |
| InChIKey | WHGZQGGHIXGBCA-VIFPVBQESA-N |
| Mol Weight | 301.27 g/mol |
| Molecular Formula | C12H16FN3O5 |
| Exact Mass | 301.107399 g/mol |
| Enantiomer InChIKey | WHGZQGGHIXGBCA-SECBINFHSA-N |
| Racemate InChIKey | WHGZQGGHIXGBCA-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
(R)-ETHYL-2-[2-(5-FLUORO-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-ACETAMIDO]-3-METHYLBUTANOATE
(R)-METHYL-2-[2-(5-FLUORO-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-ACETAMIDO]-4-(METHYLTHIO)-BUTANOATE
1-[(1',4',5',6'-Tetrahydro-4'-ethyl-2'-pyrimidinyl)methyl]-thymine - hydrochloride
1-[(1',4',5',6'-Tetrahydro-5',5'-dimethyl-2'-pyrimidinyl)methyl]-thymine - hydrochloride
1-[(4',5'-Dihydro-4',4'-dimethyl-3H-imidazol-2'-yl)methyl]-thymine - hydrochloride
1 -(3 -(4 -Aminobenzenesulfonamido) -3 -oxopropyl) -5 -fluoropyrimidine-2,4 -dione
2-[(4-Chlorophenyl)methyl]amino-3-diethylamino-1-(2,4-dioxo-5-methylpyrimidin-1-yl)-propane
1-(3,4-Dehydrotetrahydro-2-furanyl)-5-fluorouracil
(RS)-1-{[3-(2-Hydroxyethoxy)-1-methoxy]propyl}-5-fluorouracil
3-Diethylamino-1-(2,4-dioxo-5-methylpyrimidin-1-yl)-2-[(4-methoxyphenyl)methyl]aminopropane
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and Antitumor Activity of Amino Acid Ester Derivatives Containing 5-Fluorouracil | Molecules | 2009 |